Vaishali Pharma Limited (VAISHALI) — Capital Reinvestment Ratio
Vaishali Pharma Limited (VAISHALI) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs20.46 Million) in capital expenditures (Rs4.60 Million). See VAISHALI equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vaishali Pharma Limited Capital Reinvestment Ratio (2013–2024)
This chart tracks Vaishali Pharma Limited's Capital Reinvestment Ratio across 9 annual periods. Check Vaishali Pharma Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Vaishali Pharma Limited (2013–2024)
Year-by-year Capital Reinvestment Ratio for Vaishali Pharma Limited from 2013 to 2024. For live market cap and broader valuation context, see VAISHALI market cap overview.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | Rs8.07 Million | Rs1.11 Million | ▼ -50.0% |
| 2023 | 0.28x | Rs10.80 Million | Rs2.97 Million | ▼ -58.0% |
| 2022 | 0.66x | Rs13.19 Million | Rs8.65 Million | ▲ +946.8% |
| 2021 | 0.06x | Rs20.11 Million | Rs1.26 Million | ▲ +283.4% |
| 2020 | 0.02x | Rs32.19 Million | Rs526.04K | ▼ -84.3% |
| 2019 | 0.10x | Rs28.48 Million | Rs2.96 Million | ▲ +2431.8% |
| 2017 | 0.00x | Rs8.52 Million | Rs35.00K | ▼ -77.7% |
| 2016 | 0.02x | Rs45.88 Million | Rs847.00K | ▲ +469.9% |
| 2013 | 0.00x | Rs37.97 Million | Rs123.00K | — |